Telix Pharmaceuticals
TLX.AX
#2438
Rank
NZ$10.28 B
Marketcap
$30.73
Share price
-4.07%
Change (1 day)
142.33%
Change (1 year)

Telix Pharmaceuticals (TLX.AX) - P/B ratio

P/B ratio as of March 2025 : 57.0

According to Telix Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 17.1.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Telix Pharmaceuticals - P/B ratio (from 2018 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-3121.9-23.31%
2022-12-3128.6-97.21%
2021-12-31> 10007532.09%
2020-12-3113.4139.46%
2019-12-315.60108.8%
2018-12-312.68